# Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode

> **NCT00080314** · PHASE3 · COMPLETED · sponsor: **Otsuka Pharmaceutical Development & Commercialization, Inc.** · enrollment: 400 (—)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Aripiprazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00080314
- **Lead sponsor:** Otsuka Pharmaceutical Development & Commercialization, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 400 (—)
- **Last updated:** 2013-11-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00080314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00080314, "Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00080314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*